메뉴 건너뛰기
Clinical Research in Cardiology
Volumn 95, Issue SUPPL. 6, 2006, Pages
Lipometabolic disorder - Cholesterol and triglycerides;Fettstoffwechselstörungen - Cholesterin und triglyceride
Author keywords

Glycemic index; Hypercholesterolemia; Hypertriglyceridemia; Obesity
Indexed keywords

ALCOHOL; ANTILIPEMIC AGENT; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC RECEPTOR; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;
EID: 33749421468     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-1804-6     Document Type: Review
Times cited : (4)
References (7)
  • 1
    • 11144355354 scopus 로고    scopus 로고
    • Intensive versus moderate lipid lowering with statins after acute coronary syndromes
    • Cannon CP et al (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350(15):1495
    • (2004) N Engl J Med , vol.350 , Issue.15 , pp. 1495
    • Cannon, C.P.1
  • 2
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with Simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with Simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7
    • (2002) Lancet , vol.360 , pp. 7
  • 3
    • 33749378832 scopus 로고    scopus 로고
    • http://www.lipid-liga.de
  • 4
    • 15944410609 scopus 로고    scopus 로고
    • Intensive lipid lowering with atorvastatin in patients with stable coronary disease
    • LaRosa JC, Grundy SM, Waters DD et al (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352:1425
    • (2005) N Engl J Med , vol.352 , pp. 1425
    • LaRosa, J.C.1    Grundy, S.M.2    Waters, D.D.3
  • 5
    • 2542461241 scopus 로고    scopus 로고
    • Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal
    • O'Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R (2004) Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal. J Am Coll Cardiol 43:2142
    • (2004) J Am Coll Cardiol , vol.43 , pp. 2142
    • O'Keefe, J.H.1    Cordain, L.2    Harris, W.H.3    Moe, R.M.4    Vogel, R.5
  • 6
    • 0036998076 scopus 로고    scopus 로고
    • Addition of glucose to a fatty meal delays chylomicrons and suppresses VLDL in healthy subjects
    • Westphal S et al (2002) Addition of glucose to a fatty meal delays chylomicrons and suppresses VLDL in healthy subjects. Eur J Clin Invest 32:322
    • (2002) Eur J Clin Invest , vol.32 , pp. 322
    • Westphal, S.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.